KMNCF yields 3.66% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 9
Combined, KMNCF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KMNCF + JNJ for your $10,000?
Kingsmen Creatives Ltd., an investment holding company, engages in exhibitions and thematic, retail and corporate interiors, research and design, and alternative marketing businesses. The company's Exhibitions and Thematic segment produces exhibition displays for trade shows and promotional events; interiors and displays for museums and visitor centers; and thematic and scenic displays for theme parks, as well as develops and operates intellectual property for experimental and themed attractions. Its Retail and Corporate Interiors segment provides interior fitting-out services to retail and commercial properties. The company's Research and Design segment offers design works for upmarket specialty stores, departmental stores, eateries, museums, visitors' centers, corporate offices, showrooms, trade shows, events, promotional functions, and festivals. Its Alternative Marketing segment provides event management, branding consultancy, and custom publishing services. In addition, the company provides design consultancy and planning management, exhibition organizers, consultancy event management, advertising, marketing communications, electrical engineering, and graphic design and production services, as well as design and construction facilities to exhibitors. Further, it designs and produces architectural interiors, decorations, and museums; operates as an advertising contractor and agent; provides corporate marketing and other related services; and manufactures, trades, and wholesales interior and exhibition furniture, fixtures, and displays. The company operates in South Asia, North Asia, the Middle East, the United States, Canada, Europe, and internationally. Kingsmen Creatives Ltd. was founded in 1976 and is headquartered in Singapore.
Full KMNCF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.